• No results found

acute myelogenous leukemia

Computerized Detection System for Acute Myelogenous Leukemia in Blood Microscopic Images

Computerized Detection System for Acute Myelogenous Leukemia in Blood Microscopic Images

... platelets. Leukemia is detected only by observing the ...WBC’s. Leukemia is categorized into chronic leukemia and acute ...viz. Acute Lymphocytic Leukemia (ALL), Acute ...

7

Original Article Tim-3 as a leukemia stem cell specific marker expressing on bone marrow mononuclear cells is a factor for prognosis evaluation in patients with acute myelogenous leukemia

Original Article Tim-3 as a leukemia stem cell specific marker expressing on bone marrow mononuclear cells is a factor for prognosis evaluation in patients with acute myelogenous leukemia

... of acute myelogenous leukemia (AML), however, the alterations of Tim-3, as well as its marker and prognostic significance has yet to be evaluated in patients with ...

8

Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope

Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope

... The polymorphic Ia epitope recognized by monoclonal antibody 109d6 is detectable on the leukemic cells of a significantly increased number of individuals with acute myelogenous leukemia, compared ...

8

The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients

The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients

... The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling axis plays a central role in cell proliferation, growth, and survival under physiological conditions. However, aberrant ...

15

Measurement of the hypercoagulability state in Sudanese patients with acute
myelogenous leukemia in Khartoum state

Measurement of the hypercoagulability state in Sudanese patients with acute myelogenous leukemia in Khartoum state

... with acute myelogenous leukemia in Khartoum state between November 2015 and April ...were Acute Myelogenous Leukemia patients and 40 from healthy individual as control (Same age ...

7

Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells

Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells

... to leukemogenesis, and targeted therapies involving NF-κB have been designed to induce LSCs-specific apoptosis [14]. Two regulators of NF-κB that have been implicated as tumor suppressor genes, DAPK and IRF-1, have been ...

12

Pulmonary Infection Caused by Gymnascella hyalinospora in a Patient with Acute Myelogenous Leukemia

Pulmonary Infection Caused by Gymnascella hyalinospora in a Patient with Acute Myelogenous Leukemia

... We report the first case of invasive pulmonary infection caused by the thermotolerant ascomycetous fungus Gymnascella hyalinospora in a 43-year-old female from the rural midwestern United States. The patient was ...

7

Case Report Ovarian granulocytic sarcoma as the primary manifestation of acute myelogenous leukemia

Case Report Ovarian granulocytic sarcoma as the primary manifestation of acute myelogenous leukemia

... of acute myeloid leukemia (AML) or other myeloproliferative disorders, however, GS of the ovary as the primary manifestation of AML is exceed- ingly ...

5

Pretreatment of cytokinetics in acute myelogenous leukemia  Age related prognostic implications

Pretreatment of cytokinetics in acute myelogenous leukemia Age related prognostic implications

... This age-related divergent effect of cell cycle kinetics on initial response to therapy was confined to the less favorable subgroup of patients with karyotypic abnormalities, whereas pat[r] ...

7

EFFECT OF LONG- AND SHORT-TERM MINICONSOLIDATION ON SURVIVAL OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA

EFFECT OF LONG- AND SHORT-TERM MINICONSOLIDATION ON SURVIVAL OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA

... The difference between these two is the duration of therapy, The finding of in­ significant difference between these two forms of mini consolidation therapy confirm tha[r] ...

6

Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia

Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia

... In this study, we examined blood and/or bone marrow samples from relapsed/refractory AML (r/r AML) patients enrolled in phase I/II trials of guadecitabine for their DNA methylation statu[r] ...

12

On the road: Clinical trials with stem cell extended to non hematologic disease

On the road: Clinical trials with stem cell extended to non hematologic disease

... can cause immunologic rejection, so people develop trans- plantation with autologous stem cells. Fred Hutchinson Cancer Research Center [8] set the clinical studies about autologous peripheral blood stem cell transplant ...

5

Studies in Steroid Metabolism  XXVI  Steroid Isolation Studies in Human Leukemia

Studies in Steroid Metabolism XXVI Steroid Isolation Studies in Human Leukemia

... The detailed ketosteroid patterns of six subjects with chronic lymphatic leukemia during control periods and of one subject with acute myelogenous leukemia during a control interval and [r] ...

7

Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature

Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature

... Major progress for the management of invasive as- pergillosis has come from the introduction of new an- tifungals since the late 1990s. Although mortality of invasive aspergillosis remains as high as 30-50%. Back- bone ...

8

Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy

Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy

... AML: acute myelogenous leukemia; BMT: bone marrow transplantation; CBT: cord blood transplantation; CI: confidence interval; CY: cyclophosphamide; GVHD: graft-versus-host disease; GVL: graft versus ...

7

High rates of submicroscopic aberrations in karyotypically normal acute lymphoblastic leukemia

High rates of submicroscopic aberrations in karyotypically normal acute lymphoblastic leukemia

... ALL: Acute lymphoblastic leukemia; aMCB: Array-proven multicolor-banding; AML: Acute myelogenous leukemia; BAC: Bacterial artificial chromosome; B-ALL: B-cell ALL; Bp: Basepairs; CLL: ...

12

Supervise Method for Acute Lymphoblastic Leukemia Segmentation and Classification

Supervise Method for Acute Lymphoblastic Leukemia Segmentation and Classification

... of leukemia are Acute Myelogenous Leukemia (AML); Acute Lymphoblastic Leukemia (ALL); Chronic Myeloid Leukemia (CML); Chronic Lymphocytic Leukemia ...

6

Mutations of c-Cbl in myeloid malignancies

Mutations of c-Cbl in myeloid malignancies

... categories: acute myelogenous leukemia (AML) characterized by accumulation of immature myeloid cells in the bone marrow, myelodypastic syndromes (MDS) associated with ineffective hematopoiesis and ...

8

Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53 mediated apoptosis

Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53 mediated apoptosis

... The combined inhibition of the MDM2 and Bcl-2 proteins has been reported to strongly induce apoptosis in acute myelogenous leukemia cells overproducing Bcl-238 and in tumors including BL[r] ...

9

Central Nervous System Leukemia and Lymphoma: Computed Tomographic Manifestations

Central Nervous System Leukemia and Lymphoma: Computed Tomographic Manifestations

... Of the 1 56 leukem ic patients without leukemic masses , 148 acute lymphocytic leukemia, 124; acute myelogenous leukemia, 24 had documented active leptomeningeal disease on the basis of [r] ...

7

Show all 10000 documents...

Related subjects